South Korea-based in vitro diagnostic (IVD) products manufacturer Seegene has launched STAgora, a next-generation platform for infectious disease analytics.
The advanced platform combines diagnostic data with advanced statistical modelling to transform the detection, tracking, and response to outbreaks on a global scale.
It offers real-time insights, enhancing the ability of healthcare professionals to make informed decisions in managing infectious diseases.
With the launch of the STAgora platform, Seegene aims to establish a smarter, more connected global health defence system.
STAgora integrates real-time molecular diagnostics, AI-driven analytics, and global data to help build a public health infrastructure that offers proactive responses to emerging threats.
Seegene executive vice president and chief global sales and marketing officer Daniel Shin said: “During the Covid-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes.
“Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security.”
The STAgora platform provides a global visualisation of infectious disease trends at municipal, national, and continental levels.
Also, it generates immediate, structured diagnostic reports and statistical analyses in actionable formats.
The platform features customisable dashboards and real-time alert functions, enabling healthcare professionals to monitor outbreaks and respond effectively to emerging threats.
Its real-time tracking capabilities extend to both local and international regions, offering enhanced situational awareness.
By providing real-time epidemiological insights, STAgora supports national and global health authorities in developing effective response strategies to mitigate large-scale outbreaks.
It strengthens decision-making and facilitates timely, data-driven public health responses.
Seegene strategic planning head Young-Seag Baeg said: “The key differentiator of STAgora is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform.”
Equipped with more than 40 statistical tools, STAgora enables early detection of pathogen patterns and supports predictive modelling for seasonal trends and emerging outbreaks.
The tools assist in tracking individual infections, analysing symptom-based co-infections, and calculating real-time infection rate trends, transforming static data into proactive intelligence.
STAgora performs real-time analysis of PCR-derived diagnostics, offering immediate visibility into pathogen spread.
Utilising AI-based algorithms, the platform forecasts potential future outbreaks and provides a forward-looking approach to infectious disease management.
When integrated with CURECA, Seegene’s quantitative PCR technology, STAgora enhances diagnostic insight into both single-pathogen infections and multi-pathogen co-infections.
CURECA is a fully automated, modular PCR system that operates continuously, eliminating manual processes, supporting both centralised and decentralised labs.
The advanced system offers scalable automation and flexible adoption, particularly valuable in settings with limited space or personnel.
Seegene plans to officially launch STAgora at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting in Chicago, US.
